Liver Function Tests
Hepatic enzyme panel — LFT, pattern recognition, and trending
Gopal Mehta, 45M
LFT-2026-0441 · Obstructive jaundice — post-ERCP stent · Dr. P. Singh
Cholestatic
| Analyte | Value | Unit | Reference Range | Flag |
|---|---|---|---|---|
| Total Bilirubin | 3.2 ↑ | mg/dL | 0.2–1.2 | High |
| Direct (Conjugated) Bilirubin | 2.4 ↑ | mg/dL | < 0.4 | High |
| Indirect Bilirubin | 0.8 | mg/dL | < 0.8 | Normal |
| SGOT (AST) | 78 ↑ | U/L | 5–40 | High |
| SGPT (ALT) | 92 ↑ | U/L | 7–56 | High |
| Alkaline Phosphatase (ALP) | 420 ↑ | U/L | 44–147 | High |
| GGT (Gamma-GT) | 312 ↑ | U/L | 9–48 | High |
| Total Protein | 6.8 | g/dL | 6.3–8.2 | Normal |
| Albumin | 3.4 ↓ | g/dL | 3.5–5.0 | Low |
| Globulin | 3.4 | g/dL | 2.0–3.5 | Normal |
| A/G Ratio | 1.0 ↓ | 1.2–2.2 | Low |
Cholestatic pattern: markedly elevated ALP/GGT with high direct bilirubin. Transaminases mildly elevated. Consistent with biliary obstruction — post-ERCP stent placement monitoring. Albumin borderline low — monitor hepatic synthetic function.